ABVC BioPharma, Inc. (ECOC) Gross profit 2016–2025
ABVC BioPharma, Inc. (ECOC) annual gross profit history from SEC filings — each fiscal year as reported.
$508,826FY2025 · since FY2016: $2,839 → $508,826
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $508,826 | +440.1% |
| FY2024 | -$149,607 | -121.9% |
| FY2023 | $683,368 | +94.9% |
| FY2022 | $350,711 | -24.5% |
| FY2021 | $464,329 | -31.9% |
| FY2020 | $681,582 | +482.2% |
| FY2019 | -$178,324 | — |
| FY2017 | -$32 | -101.1% |
| FY2016 | $2,839 | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More ECOC financial trends
ECOC RevenueECOC Net incomeECOC Net marginECOC Gross marginECOC Operating incomeECOC Operating marginECOC Operating cash flowECOC Free cash flowECOC Capital expendituresECOC Return on equityECOC Stock buybacksECOC Dividends paidECOC Total assetsECOC Total liabilitiesECOC Shareholders’ equityECOC overview →